Cytiva builds on 60 years of innovation with Sephadex expansion
Cytiva is opening a new, larger facility on its Uppsala site to expand its manufacturing capacity of the Sephadex and Cytodex product families.
Cytiva is opening a new, larger facility on its Uppsala site to expand its manufacturing capacity of the Sephadex and Cytodex product families.
June 29th, 2022, 1:00 - 5:30pm Venue: NUS, MD11, CRC Auditorium, Level 1, 10 Medical Drive, Singpoare 117597
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of the Twist Human Methylome Panel,…